๐ฐ Philogen Spa News
Philogen Spa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Philogen Spa. Real-time updates on events, politics, business and more.
April 2, 2024
Jaguar Health Appoints European Pharmaceutical Industry Leader as President ...
March 27, 2024
The board of directors of Philogen Spa on Wednesday approved the consolidated financial statements as of Dec. 31, 2023, which closed with a loss of EUR6.2 million compared to a net loss of EUR5.4...
November 23, 2023
Brunello Cucinelli Spa, currently on the Mid-Cap list, will take the place of CNH Industrial NV on the FTSE Italia Mib from Dec. 1, pending CNH Industrial NVs initiation of the delisting confirmed...
June 7, 2023
European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, ...
June 7, 2023
Dr. Radaelli appointed Interim Executive Director of Napo Therapeutics S.p.A., the corporation established by Jaguar Health in Italy in 2021 that focuses on expanding crofelemer access in EuropeSAN FRANCISCO
May 30, 2023
The companies have come together to commercialise Philogens speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma said in a statement.
May 30, 2023
The companies have come together to commercialise Philogens speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma said in a statement
May 30, 2023
Dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.
January 24, 2023
Velocity Clinical Research (โVelocityโ), the largest integrated research site organisation globally, today announces it has strengthened its European senior executive team with three strategic hires, as the firm continues its expansion in the region. Évelyne Newton joins as Vice President of Business Development ...
March 15, 2022
Press release content from Newswire. The AP news staff was not involved in its creation.